Medicine and Dentistry
Sickle-Cell Disease
100%
Blood Donor
31%
Mortality Rate
25%
Disease
23%
Maternal Mortality
23%
Perinatal Mortality
21%
Angiofollicular Lymph Node Hyperplasia
21%
Hydroxyurea
14%
Blood Transfusion
14%
Prevalence
13%
Lung
13%
Anemia
13%
Leg Ulcer
12%
Communicable Disease
11%
Systematic Review
10%
Portal Hypertension
10%
Polycythemia vera
10%
Delayed Diagnosis
10%
Meta-Analysis
10%
Colposcopy
10%
Microchip Electrophoresis
10%
Clinical Trial
10%
Multiple Myeloma
10%
Hemophagocytic Syndrome
10%
Oncology
10%
Newborn Care
10%
Diagnosis
10%
Quality of Life
10%
Precancerous Condition
10%
Bleomycin
10%
Vascularity
10%
Hemoglobin Variant
10%
Hemoglobins
10%
Pneumonia
10%
Cost of Illness
10%
Hodgkin's Lymphoma
10%
Hypercoagulability
10%
Immunoglobulin Producing Cell
10%
Iron
10%
Supplementation
10%
Neonatal Infant
9%
Wart Virus
9%
Obstetrics
8%
Sickle Cell
8%
Health Care Cost
8%
Hemoglobin A
6%
Odds Ratio
6%
Lymphoid Hyperplasia
6%
Combination Chemotherapy
6%
Pseudolymphoma
6%
Hematology
5%
Blood Safety
5%
Donor Selection
5%
Patient Referral
5%
Rituximab
5%
Pharmacology, Toxicology and Pharmaceutical Science
Sickle Cell Anemia
41%
Hydroxycarbamide
22%
Hematologic Disease
12%
Disease
10%
Precancer
10%
Dysglycemia
10%
Inflammation
10%
Placebo
10%
Infection
10%
Hemoglobin SC Disease
10%
Plasmodium
10%
Prevalence
9%
Human Papillomavirus
9%
Cytokine
5%
Biochemistry, Genetics and Molecular Biology
Prevalence
17%
Creatinine
13%
Hemoglobins
12%
Hypercalcaemia
10%
Laboratory Test
10%
Disease Burden
10%
Smoking
10%
Plasmodium
10%
Overall Survival
10%
Genetic Association
10%
Reference Value
10%
Wart Virus
10%
Genotyping
9%
KRAS
7%
Genomics
7%
Blood Cell Count
5%
Cross Sectional Study
5%